共 6 条
- [1] A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (12): : 2569 - 2579
- [3] The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma FRONTIERS IN ONCOLOGY, 2020, 10
- [6] New Tocilizumab (TCZ) Dosing Guidance for T-Cell Engaging Bispecific Antibody-Related Cytokine Release Syndrome ( CRS) in Patients (pts) with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL): Insights from Pooled Clinical Trial Safety Experience and Quantitative Clinical Pharmacology (qCP) Analyses BLOOD, 2023, 142